Mooren ulcer in South India: Serology and clinical risk factors

American Journal of Ophthalmology

Volumn 128, Issue 2, 1999, Pages 205-210

  Zegans, Michael E ^d   Srinivasan, M ^b   McHugh, Thomas ^a   Whitcher, John P ^d   Margolis, Todd P ^d   Lietman, Thomas ^d   Jennette, J Charles ^c   Cunningham Jr, Emmett T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ARAVIND EYE HOSPITAL   (India)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; HEPATITIS C ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; RHEUMATOID FACTOR; VIRUS ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA INJURY; CORNEA PERFORATION; CORNEA RODENT ULCER; CORNEA SURGERY; FEMALE; HEPATITIS C; HUMAN; INDIA; KERATITIS; MALE; PRIORITY JOURNAL; RHEUMATIC DISEASE; RISK FACTOR; SERODIAGNOSIS; VISUAL ACUITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, VIRAL; CORNEA; CORNEAL ULCER; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C; HEPATITIS C ANTIBODIES; HERPESVIRUS 1, HUMAN; HUMANS; INDIA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RHEUMATOID FACTOR; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; VISUAL ACUITY;

EID: 0032800316     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(99)00162-2     Document Type: Article

References (19)

1. Bowman W. The parts concerned in the operations of the eye. 1849, Case 12, p 112. Cited by Nettleship E. Chronic serpiginous ulcer of the cornea (Mooren's ulcer). Trans Ophthalmol Soc U K 1902;22:103-104.
2. Bowman W. The parts concerned in the operations of the eye. 1849, Case 12, p 112. Cited by Nettleship E. Chronic serpiginous ulcer of the cornea (Mooren's ulcer). Trans Ophthalmol Soc U K 1902;22:103-104.
3. Mooren A. Ophthalmologische Beobachturgen. 1867;A Hirshwald, Berlin.
4. Chow C.Y.C., Foster C.S. Mooren's ulcer. Int Clin Ophthalmol. 36:1996;1-13.
5. Watson P.G. Management of Mooren's ulcer. Eye. 11:1997;349-356.
6. Wilson S.E., Lee W.M., Murakami C., Weng J., Moniger G.A. Mooren-type hepatitis C virus-associated corneal ulceration. Ophthalmology. 101:1994;736-745.
7. Moazami G., Auran J.D., Wilson S.E., Srinivasan D.B. Interferon treatment of Mooren's ulcers associated with hepatitis C. Ophthalmology. 119:1995;365-366.
8. Gregory J.K., Watson C.S. Peripheral ulcerative keratitis in the collagen vascular diseases. Int Clin Ophthalmol. 36:1996;21-30.
9. Tauber J., Sainz de la Maza M., Hoang-Xuan T., Foster C.S. An analysis of therapeutic decision making regarding immunosuppressive chemotherapy for peripheral ulcerative keratitis. Cornea. 9:1990;66-73.
10. Lichtenstien M.J., Pincus T. How useful are combinations of blood tests in "rheumatic panels" in diagnosis of rheumatic diseases? J Gen Intern Med. 3:1988;435-442.
11. Hagen E.C., Daha M.R., Hermans J., et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. Kidney Int. 53:1998;743-753.
12. Lewallen S., Courtright P. Problems with current concepts of the epidemiology of Mooren's corneal ulcer. Ann Ophthalmol. 22:1990;52-55.
13. Wood T.O., Kaufman H.E. Mooren's ulcer. Am J Ophthalmol. 71:1971;417-422.
14. Gottsch J.D., Liu S.H., Stark W.J. Mooren's ulcer and evidence of stromal graft rejection after penetrating keratoplasty. Am J Ophthalmol. 113:1992;412.
15. Jennette J.C., Wilkman A.S., Falk R.J. Diagnostic predictive value of ANCA serology. Kidney Int. 53:1998;796-798.
16. Condemi J. The autoimmune diseases. JAMA. 268:1992;2882-2892.
17. Alter M.J. Epidemiology of hepatitis C. Hepatology. 26:(3 suppl 1):1997;S62-S65.
18. Heintges T., Wands J.R. Hepatitis C virus epidemiology and transmission . Hepatology. 26:1997;521-526.
19. Brown S.I., Mondino B.J. Therapy of Mooren's ulcer. Am J Ophthalmol. 98:1984;1-6.